The World of In Vitro Diagnostics Market is Anticipated to Grow High CAGR by the year end of 2023 - Business Industry Reports

The World of In Vitro Diagnostics Market is Anticipated to Grow High CAGR by the year end of 2023

Pune, India, June 2018 /BIR Press Release/- Business Industry Reports announces the publication of its research report – Global In Vitro Diagnostics (IVD) Market Research Report 2018

Market Highlights

In Vitro Diagnostics (IVD) Market subdisciplines are traditionally done in labware such as test tubes, flasks, Petri dishes, and microtiter plates. Studies conducted using components of an organism that have been isolated from their usual biological surroundings permit a more detailed or more convenient analysis than can be done with whole organisms; however, results obtained from in vitro experiments may not fully or accurately predict the effects on a whole organism. In contrast to in vitro experiments, in vivo studies are those conducted in animals, including humans, and whole plants.

The in vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. 

Regional Analysis

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Long term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2023 with strong double digit growth rate from 2016 to 2023.

Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi auto and automatic biochemistry analyzers to low and mid end market users


·         Clinical Chemistry

·         Immunoassay

·         Molecular Testing 

·         Self Monitoring of Blood Glucose (SMBG)

·         Point of Care Testing (POCT) 

·         Hematology 

·         Coagulation 

·         Microbiology 

·         Genetic Testing

·         Infectious Diagnostics

·         Histology and Cytology

Key Players

The major manufacturers covered in this report- Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, Mindray Medical International Limited, Beckman Coulter Inc, Shanghai Fosun Pharmaceutical Group, Thermo Fisher Scientific Inc, Hologic Inc, Qiagen, Cepheid, Bio-Rad Laboratories Inc, Da An Gene Co. Ltd, Shanghai Kehua Bio–Engineering Co. Ltd.

Access Complete Report at .

About us is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India